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Eukaryotic cells contain numerous RNA quality-control systems that are important for 
shaping the transcriptome of eukaryotic cells. These systems not only prevent accumulation 
of nonfunctional RNAs but also regulate normal mRNAs, repress viral and parasitic RNAs, 
and potentially contribute to the evolution of new RNAs and hence proteins. These quality-
control circuits can be viewed as a series of kinetic competitions between steps in normal 
RNA biogenesis or function and RNA degradation pathways. These RNA quality-control 
circuits depend on specific adaptor proteins that target aberrant RNAs for degradation as 
well as the coupling of individual steps in mRNA biogenesis and function.Introduction
The biogenesis and function of RNAs in eukaryotic cells 
involves a series of transitions of RNAs between differ-
ent protein complexes and subcellular compartments. 
For example, the process of mRNA biogenesis and func-
tion involves transcription, capping, splicing, polyadeny-
lation, nuclear-cytoplasmic transport, translation, and 
degradation in the cytoplasm. During these processes, 
the mRNA associates in a dynamic manner with vari-
ous complexes that both catalyze steps in biogenesis 
or function and promote exchange between the proteins 
that associate with the mRNA, thereby affecting subse-
quent events (Dreyfuss et al., 2002; Moore, 2005). Similar 
complex mechanisms of biogenesis and function occur 
for small nuclear (sn)RNAs, small nucleolar (sno)RNAs, 
tRNAs, rRNAs, and micro (mi)RNAs (reviewed in Wolin 
and Matera, 1999; Nazar, 2004; Kim, 2005). To avoid 
errors in RNA biogenesis and function, quality-control 660 Cell 131, November 16, 2007 ©2007 Elsevier Inc.mechanisms have evolved that preferentially degrade 
aberrant or nonfunctional RNAs. Here, we discuss the 
diversity, principles, and consequences of RNA quality 
control in eukaryotes.
Aberrant RNAs arise by a variety of events. For exam-
ple, aberrant mRNAs can be caused by mutations in the 
gene—such as those that create premature translation 
termination codons—that trigger rapid mRNA degra-
dation (Maquat, 2004). Aberrant RNAs also arise from 
the inherent error rate of transcription, nuclear pre-RNA 
processing, or ribonucleoprotein (RNP) assembly of oth-
erwise normal transcripts. For example, transcription of 
variant 5S ribosomal genes from a large gene family in 
frog oocytes produces some transcripts that fail to termi-
nate properly; such transcripts then misfold and are tar-
geted for degradation (Shi et al., 1996). Indeed, aberrant 
RNAs may often be produced from multigene families 
due to the reduced selective pressure on each individual Table 1. Quality Control of Cytoplasmic RNAs
RNA Defect Basis of Specificity Consequence of Quality Control
tRNA Defective tRNA 
 modification
unknown Rapid tRNA decay (RTD) by an unknown nuclease (Alex-
androv et al., 2006)
rRNA Functional defect in 
rRNA
unknown Nonfunctional rRNA decay (NRD), decay of mutant rRNA 
by an unknown mechanism (LaRiviere et al., 2006)
mRNA Aberrant translation 
termination
Recruitment of Upf proteins to 
termination complex
Nonsense-mediated decay (NMD), rapid deadenylation, 
decapping, 3′-5′ decay, and some endonuclease cleav-
ages (Isken and Maquat, 2007)
mRNA No stop codon Recruitment of Ski7p to elonga-
tion stall with no mRNA in A site 
of the ribosome
Nonstop decay (NSD), Ski7p recruitment of exosome, and 
rapid 3′-5′ degradation (van Hoof et al., 2002; Frischmey-
er et al., 2002)
mRNA Strong stall in transla-
tion elongation
Recruitment of Hbs1p and 
Dom34p to A site of the ribosome
No-Go decay (NGD), endonucleolytic cleavage, and exo-
nucleolytic decay of fragments (Doma and Parker, 2006)
mRNA Translation beyond 
normal stop codon into 
3′ UTR
Unknown, removal of 3′ UTR 
binding proteins?
Ribosome extension-mediated decay (REMD), accelerat-
ed deadenylation, and decay (Kong and Liebhaber, 2007; 
Inada and Aiba, 2005)
Figure 1. Diversity of RNA Quality-Control Systems in Eukaryotes
The figure depicts some of the known RNA quality-control systems for aberrant rRNA, mRNA, and tRNA in eukaryotic cells. These and additional 
quality-control mechanisms are summarized in Tables 1 and 2.gene copy (O’Brien and Wolin, 1994). Aberrant RNAs can 
also be produced by transcription of intergenic regions, 
which yields RNAs that lack functional characteristics 
and are thus rapidly degraded (Thompson and Parker, 
2007; Wyers et al., 2005; Davis and Ares, 2006). Finally, 
quality-control systems also repress the function of, or 
degrade, parasitic RNAs arising from repetitive elements 
and transposons.
RNA quality-control mechanisms are known to tar-
get aberrant RNAs for degradation by a few conserved 
nucleases (reviewed in Parker and Song, 2004; House-
ley et al., 2006; Isken and Maquat, 2007). Quality con-
trol in the cytoplasm is carried out by the exosome 
comprising a ten-subunit core complex that catalyzes 
3′ to 5′ exonucleolytic degradation and Xrn1p, a 5′ to 3′ 
exonuclease that requires its mRNA target molecules 
to be decapped. In the nucleus, the exosome plays the 
major role in RNA quality control, although a paralog 
of Xrn1p, termed Xrn2/Rat1p in yeast, may also affect 
nuclear RNA degradation (Fang et al., 2005; Danin-Kre-
iselman et al., 2003; Bousquet-Antonelli et al., 2000). 
In the yeast nucleus, the core exosome complex also 
associates with an additional 3′ to 5′ exonuclease 
called Rrp6p (Allmang et al., 1999; Burkard and Butler, 2000), whereas in mammals the Rrp6p ortholog, PM/
Scl100, is observed in both the cytoplasm and nucleus 
(Lejeune et al., 2003).
Quality Control of Cytoplasmic RNAs
Several quality-control mechanisms in the cytoplasm 
degrade eukaryotic mRNAs that have abnormalities in 
translation (Table 1; Figure 1). An emerging principle is 
that aberrant mRNAs can be distinguished from normal 
mRNAs by adaptor proteins that interact with the trans-
lation machinery and direct the aberrant mRNAs into a 
degradation pathway. In a pathway referred to as non-
sense-mediated decay (NMD), mRNAs with premature 
translation termination codons are distinguished from 
normal mRNAs in a process involving the conserved Upf 
proteins and their interactions with a translation termina-
tion complex (for detailed review, see Isken and Maquat, 
2007). Depending on the organism or cell type, NMD can 
target aberrant mRNAs for decapping and 5′ to 3′ deg-
radation by Xrn1p; endonucleolytic cleavage; or acceler-
ated deadenylation and 3′ to 5′ degradation by the exo-
some (Isken and Maquat, 2007). In a process referred to 
as nonstop decay (NSD), ribosomes that have reached 
the end of mRNAs lacking translation termination codons Cell 131, November 16, 2007 ©2007 Elsevier Inc. 661
Table 2. Nuclear RNA Quality Control
RNA Defect Consequences of Quality Control
tRNA (yeast) Missing modification, 
 processing defects
TRAMP-dependent adenylation and 3′-5′ decay by the exosome (Kadaba et 
al., 2004; Vanacova et al., 2005; Schneider et al., 2007)
rRNA (yeast and 
plants)
Stochastic errors or defects 
in rRNA processing and/or 
assembly
TRAMP-dependent adenylation and 3′ to 5′ decay by the exosome (Dez et 
al., 2006; Win et al., 2006; LaCava et al., 2005; J. Ecker and D. Belostotsky, 
personal communication); retention of immature ribosomes in the nucleus 
(Dez et al., 2007); adenylation by poly(A) polymerase and Rrp6-dependent 
decay (Kuai et al., 2004); nuclear 5′ to 3′ decay by Rat1p (Fang et al., 2005)
rRNA (yeast) Generation of aberrant 
rRNA by incorporation of 
5-fluorouracil
Adenylation and Rrp6p-dependent degradation (Fang et al., 2004)
5S rRNA (yeast) Mutations or defective 
processing
Ro protein-dependent decay by unknown mechanism (Shi et al., 1996; Fuchs 
et al., 2006; O’Brien and Wolin, 1994; Stein et al., 2005); adenylation and 3′ to 
5′ degradation (Kadaba et al., 2006)
SnRNAs and 
snoRNAs (yeast 
and plants)
Stochastic errors or mutant 
forms
TRAMP-dependent adenylation and 3′ to 5′ decay by exosome (Kadaba 
et al., 2006; Egecioglu et al., 2006; Win et al., 2006; LaCava et al., 2005; J. 
Ecker and D. Belostotsky, personal communication); adenylation and Rrp6p-
dependent degradation (Davis and Ares, 2006)
mRNA (yeast) Hyperadenylation/hypoad-
enylation; defects in THO/
Sub2 complex; defects in 3′ 
end processing
Rrp6p and/or core exosome-dependent nuclear retention and degradation of 
RNA (Hilleren et al., 2001; Rougemaille et al., 2007; Libri et al., 2002; Thom-
sen et al., 2003; Das et al., 2003, 2006; Torchet et al., 2002)
mRNA (mammals) Failure of polyadenylation or 
splicing defects
Retention of the mRNA near or at the transcription site (Custodio et al., 1999) 
mRNA (mammals) Absence of introns in a 
gene that normally contains 
introns 
Accelerated nuclear degradation dependent on 3′ poly(A) tail (Conrad et al., 
2006)
mRNA (yeast) Splicing defect: not recog-
nized by spliceosome
Export and cytoplasmic decapping and 5′ to 3′ decay (Hilleren and Parker, 
2003; Legrain and Rosbash, 1989); retention in nucleus by MLP proteins 
(Sommer and Nehrbass, 2005)
mRNA (yeast) Splicing defect; trapped 
lariat intermediate 
Nuclear degradation by exosome (Bousquet-Antonelli et al., 2000); debranch-
ing, export, and cytoplasmic 5′ to 3′ decay by Xrn1p (Hilleren and Parker, 
2003)
mRNA (yeast) Defect in capping Export and 5′ to 3′ decay by cytoplasmic Xrn1p (Schwer et al., 1998)
dsRNA (mammals) Double-stranded RNA RNA editing and nuclear retention (Zhang and Carmichael, 2001; DeCerbo 
and Carmichael, 2005)
Intergenic 
 transcripts (yeast 
and plants)
No known function after 
transcription 
TRAMP-dependent adenylation and 3′ to 5′ decay by the exosome (Thomp-
son and Parker, 2007; Wyers et al., 2005; Davis and Ares, 2006; J. Ecker and 
D. Belostotsky, personal communication); export and 5′ to 3′ degradation by 
decapping and Xrn1p (Thompson and Parker, 2007)recruit the exosome through the action of Ski7p—a para-
log of the eEF1A (eukaryotic translation elongation fac-
tor 1A)—and eRF3 (eukaryotic release factor 3) proteins, 
which interact with the ribosomal A site during elon-
gation or termination, respectively (Frischmeyer et al., 
2002; van Hoof et al., 2002). This suggests that Ski7p 
recognizes the empty A site produced when a ribosome 
reaches the 3′ end of an mRNA. Similarly, when mRNAs 
have strong pauses in elongation, the mRNA is targeted 
for endonucleolytic cleavage in a process referred to as 
No-Go decay (NGD) (Doma and Parker, 2006). NGD is 
promoted by the Hbs1 and Dom34 proteins, which are 
paralogs of the translation termination factors eRF3 and 
eRF1 (eukaryotic release factor 1) and presumably inter-662 Cell 131, November 16, 2007 ©2007 Elsevier Inc.act with the stalled ribosome. Finally, when ribosomes 
inappropriately translate and then terminate within the 
3′ UTR at least some mRNAs are destabilized in a pro-
cess referred to as ribosome extension-mediated decay 
(REMD) (Inada and Aiba, 2005; Kong and Liebhaber, 
2007).
Pathways also exist to degrade cytoplasmic rRNA and 
tRNAs that are defective in function. Specifically, yeast 
rRNAs incorporated into ribosomes that are defective in 
either peptide bond formation or the initiation of transla-
tion are degraded faster than wild-type rRNAs (LaRiviere 
et al., 2006). Similarly, yeast tRNAs that are missing mul-
tiple modifications are more rapidly degraded (Alexan-
drov et al., 2006). The manner by which these defective 
rRNAs and tRNAs are targeted for degradation remains 
to be determined. One possibility is that ribosomes or 
tRNAs that are not engaged in translation are more sus-
ceptible to general nucleases, perhaps because of the 
absence of appropriate interacting proteins.
Quality Control of Nuclear RNAs
Numerous quality-control systems target nuclear RNAs 
that are defective in RNA-processing events (summa-
rized in Table 2, Figure 1). These nuclear quality-control 
systems lead to three related mechanisms for preventing 
the function of the aberrant RNA. First, some defective 
RNAs are exported to the cytoplasm for degradation. For 
example, mutant yeast pre-mRNAs that are trapped as 
lariats prior to the second step of pre-mRNA splicing are 
debranched and exported to the cytoplasm for 5′ to 3′ 
digestion by Xrn1p (Hilleren and Parker, 2003). Similarly, 
some apparently nonfunctional intergenic transcripts 
appear to be exported and degraded in the cytoplasm 
(Thompson and Parker, 2007).
Aberrant or unprocessed nuclear RNAs can also be 
retained within the nucleus (Table 2). Nuclear retention 
may be important both to give time for RNA processing 
to be completed and to allow for a kinetically unfavor-
able nuclear degradation pathway to degrade the RNA 
(see below). Examples of nuclear retention of aberrant 
mRNAs include the retention of mRNAs with defects 
in splicing or polyadenylation in both yeast and mam-
malian cells (Custodio et al., 1999; Hilleren et al., 2001; 
Jensen et al., 2001). Interestingly, these aberrant RNAs 
are retained in the vicinity of the gene (Custodio et al., 
1999; Thomsen et al., 2003), which has the potential 
to have feedback effects on transcription (see below). 
Similarly, long double-stranded (ds)RNAs that are 
extensively edited to contain inosines can be retained 
within the nucleus by binding a nuclear lamin-associ-
ated complex consisting of p54nrb, PSF, and matrin 
3 (Zhang and Carmichael, 2001; DeCerbo and Carmi-
chael, 2005).
Some aberrant RNAs appear to be degraded within the 
nucleus (Table 2). This conclusion is based on the obser-
vation that lesions in the nuclear 5′ to 3′ exonuclease 
Xrn2p, Rrp6p, and/or core exosome components show 
increased levels of several RNAs, processing interme-
diates, or intergenic transcripts. For example, yeast or 
plants defective in nuclear exosome function accumulate 
precursors of tRNAs, snoRNAs, snRNAs, and rRNAs, 
suggesting that some of these precursors are normally 
targeted for degradation by the exosome and are only 
revealed when the degradation process is blocked (All-
mang et al., 2000; Kadaba et al., 2004, 2006; van Hoof et 
al., 2000; Egecioglu et al., 2006; J. Ecker and D. Belosto-
tsky, personal communication). Evidence that at least the 
defective ribosomal subunits are degraded in the nucleus 
is that when degradation is inhibited, the defective ribo-
somal subunits are observed to accumulate in nuclear 
foci (Dez et al., 2006). Similarly, when mammalian intron-
containing mRNAs are lacking their introns, the resulting aberrant mRNAs are more rapidly degraded and accumu-
late in the nucleus when degradation is inhibited (Conrad 
et al., 2006).
An important aspect of RNA quality control in the 
nucleus are specialized polyadenylation complexes 
referred to as TRAMP complexes, which contain a non-
canonical poly(A) polymerase (Trf4 or Trf5 in yeast), an 
RNA-binding protein (Air1 or Air2), and an RNA helicase 
(Mtr4) (LaCava et al., 2005). Multiple lines of evidence 
argue that TRAMP complexes adenylate aberrant RNAs 
and thereby stimulate 3′ to 5′ degradation by Rrp6p and/
or the exosome by providing a single-stranded extension 
for nuclease loading. For example, many of the aberrant 
RNAs or precursors that accumulate in yeast strains or 
plants defective in nuclear exosome function contain 3′ 
poly(A) tails, which are often dependent on the action of 
Trf4 and/or Trf5 (Kadaba et al., 2004, 2006; Dez et al., 
2006; Egecioglu et al., 2006; LaCava et al., 2005; Wyers 
et al., 2005; J. Ecker and D. Belostotsky, personal com-
munication). Moreover, experiments in vitro have shown 
that polyadenylation of defective tRNAs can promote their 
degradation by the exosome (Vanacova et al., 2005). The 
role of polyadenylation in stimulating RNA decay by 3′ to 
5′ exonucleases—which is similar to the role of polyade-
nylation in prokaryotes—is a conserved mechanism to 
target RNAs for 3′ to 5′ destruction (Dreyfus and Regnier, 
2002). The features that dictate preferential polyadeny-
lation, and thereby degradation, of some RNAs by the 
TRAMP complex are unresolved. Possibilities include 
the specific recruitment of the TRAMP complex by RNA-
binding proteins preferentially bound to aberrant RNAs. 
Alternatively, TRAMP complexes may polyadenylate any 
exposed RNA 3′ end at some rate such that whether an 
RNA is a substrate for polyadenylation and degradation 
may simply be a kinetic competition with normal RNA 
processing and export (see below).
Several perplexing observations indicate that our 
understanding of the functions of the TRAMP and/or exo-
some complexes in nuclear RNA metabolism is incom-
plete. First, strains lacking Trf4 and Rrp6 show increased 
levels, but also increased RNA decay rates, of the inter-
genic Srg1 transcript, which is primarily degraded in 
the cytoplasm (Thompson and Parker, 2007). Second, 
in addition to their role in nuclear degradation, Rrp6p 
and the nuclear core exosome are required for retention 
of mRNAs with aberrant 3′ end processing in the vicin-
ity of the gene (Hilleren et al., 2001; Rougemaille et al., 
2007; Thomsen et al., 2003; Libri et al., 2002). Finally, 
the observable population of yeast mRNAs with defects 
in poly(A) tail lengths, or defects in the THO/Sub2 com-
plex, which promotes mRNP biogenesis and export, are 
surprisingly stable (Mandart and Parker, 1995; Hilleren 
and Parker, 2001; Rougemaille et al., 2007). One pos-
sible explanation for these observations is that aberrant 
transcripts retained at the gene have a feedback effect 
to decrease transcription, perhaps by forming RNA-DNA 
hybrids and decreasing transcriptional elongation (Huer-
tas and Aguilera, 2003), although recent nuclear run-on Cell 131, November 16, 2007 ©2007 Elsevier Inc. 663
experiments argue against this model (Rougemaille et 
al., 2007). Alternatively, nuclear degradation may occur 
in competition with assembly of the RNA-processing 
machinery on nascent transcripts. In this view, either 
transcripts are degraded so rapidly that they cannot be 
observed in the steady-state population (Thompson and 
Parker, 2007; Rougemaille et al., 2007) or the transcripts 
associate with the processing machinery and are stable 
until processed, which would prevent ongoing degrada-
tion of transcripts undergoing processing.
Quality Control of Parasitic RNAs
RNA quality-control systems, some of which involve 
the TRAMP and exosome complexes, also play a role 
in limiting the expression of RNAs from repetitive ele-
ments, transposons, and viruses. For example, the 
host antiviral protein ZAP specifically recruits the exo-
some to some viral RNAs and thereby promotes their 
degradation (Guo et al., 2007). Moreover, because 
dsRNA is often a signature of parasitic or viral tran-
scripts, metazoan cells have evolved numerous mech-
anisms to degrade or repress the function of dsRNA 
molecules including activation of the RNaseL endo-
nuclease (Malathi et al., 2007), activation of the PKR 
protein kinase (Garcia et al., 2006), and a response to 
extracellular dsRNA that activates transcription of anti-
viral genes (Alexopoulou et al., 2001). Nuclear dsRNA 
can also undergo extensive adenosine to inosine edit-
ing and then be selectively retained within the nucleus 
(DeCerbo and Carmichael, 2005). Most eukaryotic cells 
also respond to dsRNA by RNA interference (RNAi), 
wherein small-interfering (si)RNAs are generated from 
the dsRNA and then assemble into the RNA-induced 
silencing complex (RISC). The RISC:siRNA complex 
then silences the expression of RNAs with sequences 
complementary to the siRNA by RNA degradation, or in 
some cases in plants and some fungi, siRNAs-directed 
methylation helps to silence repetitive regions of the 
genome (reviewed in Meister and Tuschl, 2004; Grewal 
and Jia, 2007).
Metazoans also express a class of 24–29 nucleotide 
RNAs called rasiRNA (repeat associated small-interfer-
ing RNA) or piRNAs (piwi-associated RNA) that function 
to silence transposons, repetitive sequences, and some 
heterochromatic regions (reviewed in Hartig et al., 2007; 
Saito et al., 2006). Generally, numerous  piRNAs are pro-
duced from genomic clusters, often have homology to 
repetitive elements, and assemble with members of the 
PIWI protein family, which are related to the Argonaute 
proteins that are the core component of the RISC com-
plex for siRNAs and miRNAs. The mechanisms by which 
piRNAs and PIWI proteins silence their targets are not 
yet clear but may involve aspects of RNA degradation 
as well as chromatin modifications and repression of 
transcription. Thus, this system of piRNAs represents a 
mechanism to repress the function of transposons and 
repetitive RNAs and, like other quality-control systems, 
is also likely to regulate some normal mRNAs.664 Cell 131, November 16, 2007 ©2007 Elsevier Inc.Recent observations also suggest connections 
between silencing by small RNAs and degradation of RNA 
by the TRAMP and exosome complexes. For example, in 
fission yeast, efficient silencing of centromeric regions 
by small RNAs involves TRAMP-dependent targeting of 
some transcripts to Rrp6p and/or the exosome (Buhler 
et al., 2007). Defects in the exosome also reduce silenc-
ing at the mating type locus, suggesting that silencing 
of heterochromatic regions may sometimes involve RNA 
degradation of nascent transcripts (Buhler et al., 2007). 
Moreover, in Chlamydomonas reinhardtii, a noncanoni-
cal poly(A) polymerase is required for efficient decay 
of siRNA-targeted transcripts and appears to stimulate 
their exosome-dependent decay (Ibrahim et al., 2006). 
Finally, Arabidopsis plants defective in exosome function 
accumulate transcripts from regions highly coincident 
with repetitive elements and DNA methylation includ-
ing multiple small RNA-producing loci (J. Ecker and D. 
Belostotsky, personal communication), suggesting that 
RNA degradation may commonly contribute to silencing 
of heterochromatic regions.
Kinetic Competition and Quality Control
A key to effective quality-control systems is accurate 
mechanisms to distinguish between aberrant and nor-
mal RNAs. A unifying principle is that quality-control 
circuits for RNA often can be viewed as kinetic competi-
tions between the rate of a normal reaction in the life of 
an RNA and a quality-control event targeting the RNA for 
degradation (Figure 2). For example, the process of NGD 
appears to be the result of a competition between trans-
lation elongation and interaction of the Hbs1/Dom34 
complex with the stalled ribosome (Doma and Parker, 
2006). Note that if an aberrant RNA undergoes multiple 
cycles of quality control to determine whether it is nor-
mal or aberrant, then the overall effectiveness of quality 
control can be quite high even if the absolute difference 
in the rate between degradation and function at each 
cycle is small.
Examination of quality-control systems reveals 
recurring mechanistic features, often used in combina-
tions, by which the efficiency of quality control and its 
cost can be optimized. First, some aberrant RNAs or 
RNPs have features that decrease the rate of the nor-
mal forward reaction, thereby giving more time for qual-
ity control (Figure 2B(i)). For example, assembly of the 
spliceosome, but failure to complete splicing, impedes 
nuclear mRNA export, at least in yeast (Legrain and 
Rosbash, 1989). Therefore, the completion of pre-
mRNA processing prevents nuclear RNA degradation 
by removing inhibitors of export from the transcript. 
Second, some normal RNAs have features that pro-
mote the downstream normal event (Figure 2B(ii)). For 
example, nuclear pre-mRNA splicing also exerts a pos-
itive effect on transport to the cytoplasm by delivering 
export factors to the mRNA (Zhou et al., 2000; Cheng et 
al., 2006; Reed and Cheng, 2005). Finally, some aber-
rant RNAs have features that promote their recognition 
by specific adaptor proteins that funnel those RNAs 
into the quality-control fate (Figure 2B(iii)). For example, 
the Ro protein binds to variant and misfolded 5S RNAs 
that contain an aberrant 3′ extension and may target 
them for degradation (O’Brien and Wolin, 1994; Shi et 
al., 1996; Stein et al., 2005; Fuchs et al., 2006).
An important feature of kinetic competitions leading 
to quality control is that any defect leading to a delay in 
the normal forward reaction will trigger quality control. In 
this manner, quality-control systems do not need to rec-
ognize specific defective features of an RNA or RNP but 
instead can function on a broad range of defects affect-
ing the rate of a given step in biogenesis or function. One 
example of this phenomenon is in yeast where a vari-
ety of defects in proteins affecting 3′ end processing, 
hypoadenylation, or hyperadenylation of mRNAs all lead 
to retention of the aberrant mRNAs at the gene in a man-
ner that can be suppressed by loss of Rrp6p (Hilleren et 
al., 2001; Rougemaille et al., 2007; Thomsen et al., 2003; 
Libri et al., 2002).
Consequences of Quality Control
One consequence of RNA quality control is that some 
“normal” RNAs will be subjected to degradation by 
quality control. For example, approximately 1% of the 
yeast mRNAs with a wild-type intron are estimated to 
be degraded at the second step of pre-mRNA splicing 
(Hilleren and Parker, 2003). Although these discarded 
mRNAs could represent errors in splicing such as the 
use of aberrant 5′ splice sites or branch points, they 
could simply reveal the cost of this specific quality-con-
trol circuit. Moreover, cells use quality-control circuits 
to control the levels of normal transcripts. For example, 
microarray analysis has revealed that levels of several 
“normal” mRNAs are reduced by the NMD pathway 
(reviewed in Isken and Maquat, 2007). Similarly, the levels 
of the yeast histone mRNAs are reduced in abundance 
by the TRAMP and nuclear exosome systems (Reis and 
Campbell, 2007). Cells also use the regulation of pre-
mRNA splicing to produce mRNAs that are targeted to 
NMD, thereby downregulating the levels of transcripts 
from specific genes (Matlin et al., 2005). Thus, quality-
control systems play a role in determining the levels of 
accumulation of normal RNAs.
The existence of RNA quality-control systems argues 
that numerous steps in RNA biogenesis have relatively 
low fidelity and a substantial population of transcripts 
is rapidly degraded. One example of this phenomenon 
is the process of 3′ end formation and polyadenylation 
of mRNAs in yeast. In yeast cDNA databases, approxi-
mately 1% of the ESTs correspond to mRNAs aberrantly 
polyadenylated within the coding region (Graber et al., 
1999). Because these “nonstop” mRNAs are degraded 
at least ten-fold faster than the normal mRNA pool, this 
implies that up to 10% of the polyadenylation reactions 
occur inappropriately within coding regions of genes 
(van Hoof et al., 2002). In addition, strains defective in 
NMD accumulate mRNAs from a number of genes where Figure 2. Kinetic Competition and RNA Quality Control
(A) A general model for quality-control circuits as a kinetic competition 
between the rate of normal function in the life of an RNA and a quality-
control event that targets the RNA for degradation. 
(B) Three ways in which aberrant RNAs can be preferentially chan-
neled into different quality-control fates. (i) Aberrant RNAs are defec-
tive in normal function. (ii) Normal mRNAs promote normal function 
and thereby reduce quality control. (iii) Aberrant ribonucleoproteins 
(RNPs) recruit quality-control machinery.Cell 131, November 16, 2007 ©2007 Elsevier Inc. 665
the transcript has been aberrantly polyadenylated at 
sites distal to the normal poly(A) site (Jungwirth et al., 
2001). These observations indicate that polyadenylation 
occurs at a variety of both premature and distal sites, 
but these mRNAs are then rapidly degraded by either 
nonstop or NMD mechanisms. Thus, RNA processing 
creates a diverse pool of transcripts; only those that 
survive quality control accumulate to substantial levels. 
Note that the ability to degrade the products of errors 
in RNA processing allows the cell to maintain a more 
flexible RNA-processing machinery, which allows for 
increased regulation of RNA-processing patterns and 
for the evolution of new RNAs.
This “Darwinian” view of mRNA biogenesis suggests 
that quality-control mechanisms might also function as 
an evolutionary capacitor, which is a system that silences 
the phenotypic consequences of mutations, thereby 
allowing a population to build up greater genetic diversity, 
which can then be revealed at a later time (Rutherford 
and Lindquist, 1998). In this case, mRNA quality control 
allows for the accumulation of mutations, or alternate 
RNA-processing patterns, by silencing their phenotypic 
consequences. However, under conditions where mRNA 
quality control is compromised, or additional mutations 
occur that allow specific mRNAs to evade a limiting qual-
ity-control system, the phenotypic consequences would 
be revealed. Consistent with a possible role of aberrant 
RNAs in evolving new functions, some intergenic tran-
scripts in yeast are exported to the cytoplasm and even 
associate with polysomes (Thompson and Parker, 2007). 
Thus, mRNA quality-control systems may not only have 
important roles to play in the day-to-day operation of the 
cell but may also make long-term contributions to evo-
lutionary change.
Future Issues in Quality Control
Over the last five years, a wide range of RNA quality-
control mechanisms in eukaryotic cells have been 
revealed. It is now important to refine our understanding 
of the molecular mechanisms that allow these systems 
to distinguish between “normal” and “aberrant” RNAs. 
This will allow insight into the specificity of gene expres-
sion and will have medical implications. For example, 
one class of disease-causing mutations results in the 
formation of nonsense codons that lead to degradation 
of the mutant mRNA (Mendell and Dietz, 2001). Indeed, 
clinical trials are currently underway to test drugs that 
promote read-through of nonsense codons for the treat-
ment of muscular dystrophy and cystic fibrosis (Welch 
et al., 2007). Moreover, defects in RNA quality-control 
systems may lead to a variety of human diseases. For 
example, mutations in the human Upf3b protein, which 
is part of the NMD pathway, have been shown to lead to 
mental retardation (Tarpey et al., 2007).
One anticipates that the genomic scale and diver-
sity of eukaryotic RNA quality-control mechanisms will 
continue to expand. Transcripts from large stretches of 
eukaryotic genomes now can be detected at low levels 666 Cell 131, November 16, 2007 ©2007 Elsevier Inc.(reviewed in Bickel and Morris, 2006), many of which 
may be substrates for RNA quality-control mechanisms. 
Indeed, recent experiments in Arabidopsis using tiling 
microarrays—which use oligonucleotides to detect tran-
scripts from any region of the genome—to examine the 
amount and diversity of RNAs present when exosome 
function is inhibited have revealed significant popula-
tions of transcripts that appear to be produced but rap-
idly degraded and hence are only observed at very low 
levels under normal conditions (J. Ecker and D. Belosto-
tsky, personal communication).
One expects that new classes of quality-control mech-
anisms will emerge where defects in RNPs lead not to 
degradation of the transcript but to repair of the defect. 
For example, RNA polymerase II can repair defects in 
transcriptional elongation by degrading the 3′ end of the 
nascent transcript, resulting in restarting elongation a 
few nucleotides back on the template (Fish and Kane, 
2002). Similarly, in yeast it has been suggested that the 
exosome can process aberrant 3′ extended mRNAs 
in yeast to restore their function (Torchet et al., 2002). 
Moreover, systems may exist to repair chemical dam-
age to RNA such as demethylation of methyl lesions 
(Falnes et al., 2007). Indeed, as our understanding of the 
diversity of RNA quality-control pathways matures, the 
relevant question may become: What stage of RNA bio-
genesis and function is not subject to quality control?
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